Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Cell Therapy Market Evolve in Terms of Growth and Size by 2029?

The market size for cell therapy has seen a quick expansion in the past few years. It’s projected to rise from $14.56 billion in 2024 to $16.87 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.8%. Factors contributing to the growth during the historical period include early investigations and discoveries, regulatory accomplishments, clinical research and trials, early adopting firms and innovators, as well as market reception and perception.

The market size of cell therapy is anticipated to experience significant expansion in the upcoming years. It’s projected to reach “$28.67 billion by 2029 with a compound annual growth rate (CAGR) of 14.2%. This surge during the prediction period is due to factors such as societal and ethical considerations, trends in investments and funding, demand from patients or consumers, the state of healthcare facilities, and fast-paced innovation cycles. The forecast period will also see key trends like personalized medicine, the rise of target-specific treatments, advancements in gene editing technologies, the broadening scope of stem cell research, improvements in immunotherapy, and manipulation of the microenvironment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What factors are expected to fuel Cell Therapy market growth in the coming years?

The surge in chronic diseases has contributed to the growth of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) characterizes chronic disease as an illness lasting a year or more that necessitates medical care, hinders daily activities, or both. This includes conditions like heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells have the potential to assist patients with conditions such as spinal cord injuries, type 1 diabetes, Parkinson’s disease, heart disease, cancer, and osteoarthritis. As an illustration, in July 2024, the Centers for Disease Control and Prevention (CDC), a national public health organization in the U.S., disclosed significant advancements in public health initiatives. Heart disease or stroke lead to the death of over 944,800 Americans annually, representing more than one-third of all deaths. In the U.S., yearly cancer diagnoses are approximately 1.7 million individuals, with over 600,000 ultimately succumbing to the disease, making it the second leading cause of death. Furthermore, over 38 million Americans have diabetes, and another 98 million adults are prediabetic, thus increasing their potential for developing type 2 diabetes. Diabetes can trigger serious complications like heart disease, renal failure, and blindness. Meanwhile, obesity affects 20% of children and 42% of adults, thereby increasing susceptibility to chronic diseases such as type 2 diabetes, heart disease, and certain cancers. The escalating prevalence of chronic diseases has intensified the need for cell therapies, thereby facilitating the expansion of the cell therapy market.

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

What Future Market Trends Are Projected For The Cell Therapy Industry?

Major participants in the market are tactically associating and working together to broaden their range of products and extend their coverage across different regions. Ajinomoto Co Inc., a food firm based in Japan, took over Forge Biologics for a sum of $620 million in November 2023. This procurement is part of Ajinomoto Co Inc.’s strategy to enhance its worldwide competency in AAV and plasmid gene therapy manufacturing, thereby amplifying its current contract development and manufacturing services. Forge Biologics, on the other hand, is a biotechnology firm in the US that focuses on progressing cell therapy technologies for treating a variety of diseases.

What Are The Most Active Companies In The Cell Therapy Market Today?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Regional Markets Are Attracting The Most Investment In Cell Therapy?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model